Results 171 to 180 of about 24,885,885 (288)

THE EFFECTS OF LOW LEVEL LASER THERAPY ON PROLIFERATION AND DIFFERENTIATION OF MESENCHIMAL STEM CELLS: A LITERATURE REVIEW

open access: yes, 2019
Utilization of a low-energy light intensity within the visible red and near infrared portion of the electromagnetic spectrum has been shown to stimulate irradiated cellular activity. This phenomenon has been referred to as photobiomodulation (PBM) or low
Meleti Marco   +5 more
core  

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy for Demodex-Associated Blepharitis

open access: yesClinical Ophthalmology
Sarah Farrant,1 Giuseppe Giannaccare,2 Chris Hong Long Lim,3– 5 Giulia Coco6 1Earlam and Christopher Optometrists Ltd, Taunton, UK; 2Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy; 3Department of Ophthalmology ...
Farrant S   +3 more
doaj  

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Optimisation of low-level light therapy (lllt) parameters and evaluation of its immunomodulatory effect on fibroblasts. [PDF]

open access: yesLasers Med Sci
Ścisłowska-Czarnecka A   +6 more
europepmc   +1 more source

Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome. [PDF]

open access: yesJ Ophthalmol, 2021
Di Marino M   +9 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

The effect of photobiomodulation versus placebo on functional capacity and fatigability in post COVID-19 elderly

open access: yesAdvances in Rehabilitation, 2022
Rana Elbannaa   +3 more
doaj   +1 more source

Effects of Low-Level Light Therapy (LLLT) on Oxidative Stress in the Cutaneous Healing Process: A Literature Review. [PDF]

open access: yesJ Lasers Med Sci
Irber PF   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy